Rhythm Pharmaceuticals (RYTM) Free Cash Flow (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Free Cash Flow of -$43.8 million for Q1 2026, down 8.7% year-over-year from -$47.9 million in Q1 2025, and down 67.82% quarter-over-quarter from -$26.1 million in Q4 2025.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Free Cash Flow (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Free Cash Flow for 11 consecutive years, with -$43.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 8.7% year-over-year to -$43.8 million; the TTM figure through Mar 2026 stood at -$119.6 million (down 4.36% YoY), while the FY2025 annual figure was -$116.1 million, down 1.93% from the prior year.
- Free Cash Flow fell to -$43.8 million in Q1 2026 per RYTM's latest filing, from -$26.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$17.9 million in Q2 2025 and bottomed at -$53.8 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$34.2 million across 5 years, with a median of -$31.9 million in 2025.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 60.27% — and 2023, when it jumped 44.4%.
- Rhythm Pharmaceuticals' Free Cash Flow stood at -$29.4 million in 2022, then grew by 0.18% to -$29.4 million in 2023, then advanced by 25.13% to -$22.0 million in 2024, then dropped by 18.49% to -$26.1 million in 2025, then slumped by 67.82% to -$43.8 million in 2026.
- Business Quant data shows RYTM's Free Cash Flow at -$43.8 million in Q1 2026, -$26.1 million in Q4 2025, and -$31.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Rhythm Pharmaceuticals | 7.04 Bn | 6.71 Bn | 62.32 Mn | -9.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.15 Mn |
| Mar 31, 2026 | -43.75 Mn |
| Dec 31, 2025 | -26.63 Mn |
| Sep 30, 2025 | -31.86 Mn |
| Jun 30, 2025 | -17.89 Mn |
| Mar 31, 2025 | -40.25 Mn |
| Dec 31, 2024 | -14.06 Mn |
| Sep 30, 2024 | -24.31 Mn |
| Jun 30, 2024 | -28.02 Mn |
| Mar 31, 2024 | -39.55 Mn |
| Dec 31, 2023 | -29.39 Mn |
| Sep 30, 2023 | -28.71 Mn |
| Jun 30, 2023 | -39.87 Mn |
| Mar 31, 2023 | -36.53 Mn |
| Dec 31, 2022 | -34.00 Mn |
| Sep 30, 2022 | -47.86 Mn |
| Jun 30, 2022 | -36.12 Mn |
| Mar 31, 2022 | -60.29 Mn |
| Dec 31, 2021 | -41.75 Mn |
| Sep 30, 2021 | -50.43 Mn |